Avance Clinical will attend BIO KOREA 2026, Korea’s leading international bio-health convention, connecting with biotech innovators from across Asia, North America, and Europe. Join us at the Australian Pavilion to learn how our fully integrated Global footprint delivers faster start-up, global-ready data, and seamless multi-region trial execution.
With our Asia operations hub in Seoul and additional offices in Taiwan, Avance Clinical provides seamless, multi‑region clinical development pathways across both early and later phases. BIO KOREA is an ideal opportunity to discuss how we support biotechs globally:
We provide a clear route to global development — starting with rapid early‑phase clinical trials in Australia for fast proof‑of‑concept, followed by expansion into North America and other key markets. Our integrated regional infrastructure minimises operational complexity while maintaining speed, regulatory rigour and data integrity.
We offer a structured entry into Asia for cost‑efficient later‑phase clinical trials, access to large and diverse patient populations, and accelerated recruitment across oncology, metabolic, infectious, hepatic, renal and CNS indications.
Avance Clinical specializes in helping biotechs unlock the benefits of conducting early-phase clinical trials in Australia, including:
These advantages support faster proof-of-concept, lower costs, and a smoother transition to later-phase trials in North America and Europe.
Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.
Level 22, 91 King William Street
Adelaide, SA
Australia 5000
Phone: +61 8 8249 4788
For all media enquiries: media@avancecro.com
